|
 |
|
Total Number of Holdings (excluding cash): 84
United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals and Biotechnology |
128,839 |
$29,100,864.93 |
2.23% |
Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Pharmaceuticals and Biotechnology |
118,423 |
$28,673,760.99 |
2.20% |
Encompass Health Corporation |
EHC |
29261A100 |
Health Care Providers |
420,067 |
$28,211,699.72 |
2.16% |
Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals and Biotechnology |
2,849,921 |
$28,100,221.06 |
2.16% |
DaVita Inc. |
DVA |
23918K108 |
Health Care Providers |
283,098 |
$26,761,253.94 |
2.05% |
Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals and Biotechnology |
300,757 |
$26,111,722.74 |
2.00% |
Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Pharmaceuticals and Biotechnology |
31,670 |
$26,063,143.20 |
2.00% |
Biogen Inc. |
BIIB |
09062X103 |
Pharmaceuticals and Biotechnology |
99,841 |
$25,660,135.41 |
1.97% |
Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals and Biotechnology |
775,422 |
$25,720,747.74 |
1.97% |
Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals and Biotechnology |
2,261,797 |
$25,422,598.28 |
1.95% |
Moderna, Inc. |
MRNA |
60770K107 |
Pharmaceuticals and Biotechnology |
234,099 |
$24,180,085.71 |
1.85% |
The Cigna Group |
CI |
125523100 |
Health Care Providers |
81,081 |
$23,194,841.67 |
1.78% |
HCA Healthcare, Inc. |
HCA |
40412C101 |
Health Care Providers |
93,714 |
$23,051,769.72 |
1.77% |
Universal Health Services, Inc. (Class B) |
UHS |
913903100 |
Health Care Providers |
180,270 |
$22,665,347.10 |
1.74% |
ICON Plc |
ICLR |
G4705A100 |
Medical Equipment and Services |
90,949 |
$22,396,191.25 |
1.72% |
Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals and Biotechnology |
64,663 |
$22,485,911.62 |
1.72% |
Elevance Health Inc. |
ELV |
036752103 |
Health Care Providers |
51,216 |
$22,300,470.72 |
1.71% |
Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals and Biotechnology |
295,228 |
$22,124,386.32 |
1.70% |
Premier, Inc. (Class A) |
PINC |
74051N102 |
Health Care Providers |
1,028,276 |
$22,107,934.00 |
1.70% |
Laboratory Corporation of America Holdings |
LH |
50540R409 |
Medical Equipment and Services |
109,747 |
$22,064,634.35 |
1.69% |
Integra LifeSciences Holdings Corporation |
IART |
457985208 |
Medical Equipment and Services |
553,221 |
$21,127,509.99 |
1.62% |
Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals and Biotechnology |
76,860 |
$20,656,893.60 |
1.58% |
Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals and Biotechnology |
355,798 |
$20,650,515.92 |
1.58% |
Exact Sciences Corporation |
EXAS |
30063P105 |
Pharmaceuticals and Biotechnology |
302,903 |
$20,664,042.66 |
1.58% |
Stryker Corporation |
SYK |
863667101 |
Medical Equipment and Services |
74,586 |
$20,382,116.22 |
1.56% |
QuidelOrtho Corporation |
QDEL |
219798105 |
Medical Equipment and Services |
274,598 |
$20,056,637.92 |
1.54% |
Penumbra, Inc. |
PEN |
70975L107 |
Medical Equipment and Services |
82,675 |
$19,999,909.25 |
1.53% |
Shockwave Medical, Inc. |
SWAV |
82489T104 |
Medical Equipment and Services |
99,651 |
$19,840,514.10 |
1.52% |
Quest Diagnostics Incorporated |
DGX |
74834L100 |
Medical Equipment and Services |
161,880 |
$19,726,696.80 |
1.51% |
Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals and Biotechnology |
36,383 |
$19,542,400.79 |
1.50% |
Intuitive Surgical, Inc. |
ISRG |
46120E602 |
Medical Equipment and Services |
66,549 |
$19,451,607.21 |
1.49% |
US Dollar |
$USD |
|
Other |
19,047,401 |
$19,047,401.04 |
1.46% |
Envista Holdings Corporation |
NVST |
29415F104 |
Medical Equipment and Services |
672,391 |
$18,746,261.08 |
1.44% |
Humana Inc. |
HUM |
444859102 |
Health Care Providers |
38,175 |
$18,572,901.00 |
1.42% |
Molina Healthcare, Inc. |
MOH |
60855R100 |
Health Care Providers |
56,658 |
$18,577,591.62 |
1.42% |
Maravai LifeSciences Holdings, Inc. (Class A) |
MRVI |
56600D107 |
Pharmaceuticals and Biotechnology |
1,830,561 |
$18,305,610.00 |
1.40% |
Danaher Corporation |
DHR |
235851102 |
Medical Equipment and Services |
71,112 |
$17,642,887.20 |
1.35% |
Avantor, Inc. |
AVTR |
05352A100 |
Medical Equipment and Services |
830,836 |
$17,514,022.88 |
1.34% |
Centene Corporation |
CNC |
15135B101 |
Health Care Providers |
253,008 |
$17,427,191.04 |
1.34% |
Inspire Medical Systems, Inc. |
INSP |
457730109 |
Medical Equipment and Services |
87,610 |
$17,385,328.40 |
1.33% |
West Pharmaceutical Services, Inc. |
WST |
955306105 |
Medical Equipment and Services |
44,623 |
$16,742,995.83 |
1.28% |
DexCom, Inc. |
DXCM |
252131107 |
Medical Equipment and Services |
177,052 |
$16,518,951.60 |
1.27% |
Charles River Laboratories International, Inc. |
CRL |
159864107 |
Pharmaceuticals and Biotechnology |
81,164 |
$15,906,520.72 |
1.22% |
Henry Schein, Inc. |
HSIC |
806407102 |
Medical Equipment and Services |
210,426 |
$15,624,130.50 |
1.20% |
Natera, Inc. |
NTRA |
632307104 |
Medical Equipment and Services |
350,697 |
$15,518,342.25 |
1.19% |
Acadia Healthcare Company, Inc. |
ACHC |
00404A109 |
Health Care Providers |
214,272 |
$15,065,464.32 |
1.16% |
Align Technology, Inc. |
ALGN |
016255101 |
Medical Equipment and Services |
48,257 |
$14,733,827.24 |
1.13% |
Hologic, Inc. |
HOLX |
436440101 |
Medical Equipment and Services |
210,769 |
$14,627,368.60 |
1.12% |
Globus Medical, Inc. (Class A) |
GMED |
379577208 |
Medical Equipment and Services |
286,627 |
$14,231,030.55 |
1.09% |
Seagen Inc. |
SGEN |
81181C104 |
Pharmaceuticals and Biotechnology |
59,105 |
$12,539,125.75 |
0.96% |
UnitedHealth Group Incorporated |
UNH |
91324P102 |
Health Care Providers |
23,677 |
$11,937,706.63 |
0.92% |
Apellis Pharmaceuticals, Inc. |
APLS |
03753U106 |
Pharmaceuticals and Biotechnology |
312,208 |
$11,876,392.32 |
0.91% |
Veeva Systems Inc. (Class A) |
VEEV |
922475108 |
Health Care Providers |
57,531 |
$11,704,681.95 |
0.90% |
Amedisys, Inc. |
AMED |
023436108 |
Health Care Providers |
124,424 |
$11,621,201.60 |
0.89% |
Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals and Biotechnology |
335,115 |
$10,706,924.25 |
0.82% |
Agilent Technologies, Inc. |
A |
00846U101 |
Medical Equipment and Services |
94,611 |
$10,579,402.02 |
0.81% |
Revvity, Inc. |
RVTY |
714046109 |
Medical Equipment and Services |
95,780 |
$10,602,846.00 |
0.81% |
Medtronic Plc |
MDT |
G5960L103 |
Medical Equipment and Services |
129,133 |
$10,118,861.88 |
0.78% |
Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals and Biotechnology |
98,593 |
$10,150,149.35 |
0.78% |
QIAGEN N.V. |
QGEN |
N72482123 |
Medical Equipment and Services |
252,645 |
$10,232,122.50 |
0.78% |
IQVIA Holdings Inc. |
IQV |
46266C105 |
Health Care Providers |
50,613 |
$9,958,107.75 |
0.76% |
Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals and Biotechnology |
546,702 |
$9,490,746.72 |
0.73% |
Enovis Corp. |
ENOV |
194014502 |
Medical Equipment and Services |
177,432 |
$9,355,989.36 |
0.72% |
Teleflex Incorporated |
TFX |
879369106 |
Medical Equipment and Services |
47,014 |
$9,234,019.74 |
0.71% |
Masimo Corporation |
MASI |
574795100 |
Medical Equipment and Services |
103,708 |
$9,093,117.44 |
0.70% |
Sotera Health Company |
SHC |
83601L102 |
Medical Equipment and Services |
603,874 |
$9,046,032.52 |
0.69% |
Karuna Therapeutics, Inc. |
KRTX |
48576A100 |
Pharmaceuticals and Biotechnology |
52,460 |
$8,870,461.40 |
0.68% |
10X Genomics, Inc. (Class A) |
TXG |
88025U109 |
Medical Equipment and Services |
203,746 |
$8,404,522.50 |
0.64% |
Exelixis, Inc. |
EXEL |
30161Q104 |
Pharmaceuticals and Biotechnology |
297,662 |
$6,503,914.70 |
0.50% |
Repligen Corporation |
RGEN |
759916109 |
Medical Equipment and Services |
40,213 |
$6,394,269.13 |
0.49% |
Catalent, Inc. |
CTLT |
148806102 |
Pharmaceuticals and Biotechnology |
131,187 |
$5,972,944.11 |
0.46% |
agilon health, inc. |
AGL |
00857U107 |
Health Care Providers |
328,055 |
$5,826,256.80 |
0.45% |
Becton, Dickinson and Company |
BDX |
075887109 |
Medical Equipment and Services |
21,554 |
$5,572,355.62 |
0.43% |
Chemed Corporation |
CHE |
16359R103 |
Health Care Providers |
10,505 |
$5,459,448.50 |
0.42% |
Thermo Fisher Scientific Inc. |
TMO |
883556102 |
Medical Equipment and Services |
10,896 |
$5,515,228.32 |
0.42% |
Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals and Biotechnology |
34,372 |
$5,353,439.00 |
0.41% |
Incyte Corporation |
INCY |
45337C102 |
Pharmaceuticals and Biotechnology |
91,380 |
$5,279,022.60 |
0.40% |
Abbott Laboratories |
ABT |
002824100 |
Medical Equipment and Services |
52,172 |
$5,052,858.20 |
0.39% |
IDEXX Laboratories, Inc. |
IDXX |
45168D104 |
Medical Equipment and Services |
11,332 |
$4,955,143.64 |
0.38% |
Bio-Techne Corporation |
TECH |
09073M104 |
Medical Equipment and Services |
69,686 |
$4,743,526.02 |
0.36% |
Tenet Healthcare Corporation |
THC |
88033G407 |
Health Care Providers |
69,896 |
$4,605,447.44 |
0.35% |
Ultragenyx Pharmaceutical Inc. |
RARE |
90400D108 |
Pharmaceuticals and Biotechnology |
123,316 |
$4,396,215.40 |
0.34% |
Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
Medical Equipment and Services |
39,065 |
$4,383,874.30 |
0.34% |
Edwards Lifesciences Corporation |
EW |
28176E108 |
Medical Equipment and Services |
60,304 |
$4,177,861.12 |
0.32% |
Doximity, Inc. (Class A) |
DOCS |
26622P107 |
Health Care Providers |
167,207 |
$3,548,132.54 |
0.27% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|